Analystreport

Avadel Pharmaceuticals PLC (NASDAQ: AVDL) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $14.00 price target on the stock.

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com